Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumococcal vaccination--yes or no?]

T Hess1

  • 1Medizinische Klinik, Pneumologie, Kantonsspital Winterthur.

Schweizerische Medizinische Wochenschrift
|August 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is the rate of chest computed tomography different between adult and pediatric Level 1 trauma centers?

The journal of trauma and acute care surgery·2026
Same author

Lighting up PNETs: Creating Murine Models with a Novel Bioluminescent Cell Line.

Annals of surgical oncology·2026
Same author

Surgical Stabilization of Rib Fractures in Geriatric Trauma Patients: A National Trauma Data Bank Review.

Journal of the American Geriatrics Society·2026
Same author

A Single-Center Review of Renal Replacement Therapy in Patients With Acute Traumatic Brain Injury.

Cureus·2026
Same author

Use of Whole Blood in Trauma Patients on Anticoagulation or Antiplatelet Therapy.

The Journal of surgical research·2025
Same author

Activating NRF2<sup>E79Q</sup> mutation alters the differentiation of human non-small cell lung cancer.

Cancer gene therapy·2025
Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010
Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010
Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010
Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010
Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010
Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010
See all related articles

Pneumococcal vaccination is recommended for high-risk groups to prevent invasive pneumococcal infections. While effective, research is ongoing for immunocompromised individuals and new conjugate vaccines show promise.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Vaccinology

Context:

  • Invasive pneumococcal infections caused by Streptococcus pneumoniae pose a significant mortality risk, particularly in defined vulnerable populations.
  • Risk groups include the elderly, asplenic individuals, immunocompromised patients (including those with hematological neoplasias and HIV), and those with chronic cardiopulmonary diseases, diabetes, or renal failure.
  • The 23-valent polysaccharide vaccine is effective in most adults and children over 2, though immune response may be reduced in the elderly and severely immunocompromised.

Purpose:

  • To review the effectiveness and recommendations for pneumococcal vaccination in preventing invasive pneumococcal infections.
  • To discuss the limitations of current vaccines, particularly in high-risk groups, and the potential of novel conjugate vaccines.

Summary:

Related Experiment Videos

  • Pneumococcal vaccination is recommended for identified risk groups due to its proven effectiveness in preventing invasive pneumococcal infections.
  • Clinical data on vaccine effectiveness is limited for severely immunocompromised and HIV-infected individuals.
  • Booster vaccinations are generally not recommended due to potential side effects, although a single revaccination may benefit post-splenectomy patients.

Impact:

  • Pneumococcal vaccination significantly reduces the incidence of invasive pneumococcal infections in recommended populations.
  • Ongoing development of conjugate vaccines aims to enhance efficacy and expand vaccination eligibility to younger children.
  • Further research is needed to establish definitive clinical effectiveness data for certain high-risk groups.